US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Maximum Strength Acid Reducer

Reason CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Perrigo Company PLC D-1019-2020
Class II · Moderate risk Terminated

Maximum Strength Acid Reducer

Reason CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Perrigo Company PLC D-1018-2020
Class II · Moderate risk Terminated

Maximum Strength Acid Reducer

Reason CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Perrigo Company PLC D-1017-2020
Class II · Moderate risk Terminated

Regular Strength Acid Reducer

Reason CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Perrigo Company PLC D-1016-2020
Class II · Moderate risk Terminated

Regular Strength Acid Reducer

Reason CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Perrigo Company PLC D-1015-2020
Class II · Moderate risk Terminated

Regular Strength Acid Reducer

Reason CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Perrigo Company PLC D-1014-2020
Class II · Moderate risk Terminated

Regular Strength Acid Reducer

Reason CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Perrigo Company PLC D-1013-2020
Class II · Moderate risk Terminated

Regular Strength Acid Reducer

Reason CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Perrigo Company PLC D-1012-2020
Class II · Moderate risk Terminated

Alprazolam Tablets

Reason Presence of Foreign Substance

Mylan Pharmaceuticals Inc. NDC 0378-4003-05 D-0186-2020
Class II · Moderate risk Terminated

Estradiol Vaginal Inserts USP

Reason Defective Delivery System: complaints for difficulty in pushing the plunger of the applicator.

Glenmark Pharmaceuticals Inc., USA NDC 68462-711-71 D-0156-2020
Class II · Moderate risk Terminated

Basic Reset CBD Reset 2400

Reason Marketed without an Approved NDA/ANDA

Basic Reset Inc. D-0194-2020
Class II · Moderate risk Terminated

Nuovi Firming Masque

Reason Marketed without an Approved NDA/ANDA

Basic Reset Inc. D-0190-2020
Class II · Moderate risk Terminated

Basic Reset Nuovi Skin Toner

Reason Marketed without an Approved NDA/ANDA

Basic Reset Inc. D-0189-2020
Class II · Moderate risk Terminated

Miracle Facelift Masque

Reason Marketed without an Approved NDA/ANDA

Basic Reset Inc. D-0188-2020
Class II · Moderate risk Terminated

Prasugrel Tablets 5 mg

Reason Failed Dissolution Specification: Low out of specification dissolution results.

Mylan Pharmaceuticals Inc. NDC 0378-5185-93 D-0155-2020
Class II · Moderate risk Terminated

Viatrexx-ANS/CNS

Reason Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

8046255 Canada Inc. DBA Viatrexx NDC 73069-039-41 D-0348-2020